Cite
Parmar DR, Soni JY, Guduru R, et al. Discovery of new anticancer thiourea-azetidine hybrids: design, synthesis, in vitro antiproliferative, SAR, in silico molecular docking against VEGFR-2, ADMET, toxicity, and DFT studies. Bioorg Chem. 2021;115:105206doi: 10.1016/j.bioorg.2021.105206.
Parmar, D. R., Soni, J. Y., Guduru, R., Rayani, R. H., Kusurkar, R. V., Vala, A. G., Talukdar, S. N., Eissa, I. H., Metwaly, A. M., Khalil, A., Zunjar, V., & Battula, S. (2021). Discovery of new anticancer thiourea-azetidine hybrids: design, synthesis, in vitro antiproliferative, SAR, in silico molecular docking against VEGFR-2, ADMET, toxicity, and DFT studies. Bioorganic chemistry, 115105206. https://doi.org/10.1016/j.bioorg.2021.105206
Parmar, Deepa R, et al. "Discovery of new anticancer thiourea-azetidine hybrids: design, synthesis, in vitro antiproliferative, SAR, in silico molecular docking against VEGFR-2, ADMET, toxicity, and DFT studies." Bioorganic chemistry vol. 115 (2021): 105206. doi: https://doi.org/10.1016/j.bioorg.2021.105206
Parmar DR, Soni JY, Guduru R, Rayani RH, Kusurkar RV, Vala AG, Talukdar SN, Eissa IH, Metwaly AM, Khalil A, Zunjar V, Battula S. Discovery of new anticancer thiourea-azetidine hybrids: design, synthesis, in vitro antiproliferative, SAR, in silico molecular docking against VEGFR-2, ADMET, toxicity, and DFT studies. Bioorg Chem. 2021 Oct;115:105206. doi: 10.1016/j.bioorg.2021.105206. Epub 2021 Jul 27. PMID: 34339975.
Copy
Download .nbib